Current practice in atrial septal defect occlusion in children and adults

Wail Alkashkari1,2,3, Saad Albugami2, Ziyad M Hijazi4,5

  • 1Department of Cardiology, King Faisal Cardiac Center, Ministry of National Guard Health Affairs , Jeddah, Saudi Arabia.

Insights

Atrial septal defect (ASD) is a common congenital heart disease. Transcatheter closure is now the preferred treatment for secundum ASD, offering improved outcomes with recent advances in diagnosis and therapy.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Pediatric Cardiology

Background:

  • Atrial septal defect (ASD) is a frequent congenital heart disease (CHD) in all age groups.
  • It involves abnormal openings between heart atria, causing blood shunting.
  • Late diagnosis in adults can lead to pulmonary artery hypertension and heart dysfunction.

Purpose of the Study:

  • To provide a comprehensive review of atrial septal defects (ASDs).
  • To detail the anatomy, pathophysiology, clinical features, and treatment indications for ASD.
  • To focus on advancements in the diagnosis and transcatheter treatment of secundum ASDs.

Main Methods:

  • Review of ASD aspects including anatomy, pathophysiology, and clinical presentation.
  • Detailed examination of transcatheter closure therapy, devices, and outcomes.
  • Focus on recent diagnostic and therapeutic strategy updates for secundum ASDs.

Main Results:

  • Significant improvements in ASD treatment strategies over recent decades.
  • Transcatheter closure is the primary treatment for most secundum ASD cases.
  • Review highlights current best practices and recent advancements in ASD management.

Conclusions:

  • Transcatheter closure has become the gold standard for secundum ASD treatment.
  • Early diagnosis and intervention are crucial for favorable patient outcomes.
  • This review emphasizes the latest developments in secundum ASD diagnosis and treatment.
Abstract